A groundbreaking robotic system designed to revolutionize eye surgeries, particularly for vitreoretinal and cataract procedures, is making waves in the field of ophthalmology. Researchers at the University of California, Los Angeles (UCLA) have developed an advanced platform that leverages artificial intelligence (AI) and high-precision imaging to achieve unparalleled accuracy in eye surgeries.
The AI-powered robotic system, which has already shown promising results in preclinical trials, was unveiled by Dr. Aya Barzelay-Wollman, MD, PhD, co-director of the Advanced Robotic Micro Surgery (ARMS) Laboratory at UCLA, at the 2024 European Society of Retina Specialists (EURETINA) conference. The system has been hailed for its remarkable precision, with capabilities reaching a resolution of 1 micron and an accuracy of 10 microns—far surpassing the limitations of human surgeons, whose hand tremors typically range from 30 to 50 microns.
“This robot’s precision is truly unprecedented,” Dr. Barzelay-Wollman explained during her presentation. “With the ability to move in 1-micron increments and achieve targeting accuracy under 20 microns, it offers a level of precision that human hands simply cannot match.”
The robotic platform is particularly designed to address the complexities of vitreoretinal and cataract surgeries. Cataract surgery, while commonly performed, does not pose the same challenges as retinal surgery, which requires intricate maneuvering to visualize and treat the delicate structures within the eye. Traditional surgical microscopes provide a limited, top-down view of the retina, making precise navigation difficult.
To overcome this challenge, Dr. Barzelay-Wollman and her team created innovative intraocular imaging probes that attach directly to the vitrector. These probes offer real-time views of the retina, allowing the robot to perform procedures with exceptional accuracy. By integrating optical coherence tomography (OCT), the system produces high-resolution images of retinal layers, enabling it to navigate and perform surgeries with unmatched precision.
“Our system combines detailed anatomical data with real-time imaging to guide the robot’s movements during surgery,” said Barzelay-Wollman. “The integration of OCT images allows for fully automated vitrectomies, with accuracy previously unattainable in retinal surgery.”
The robotic platform operates in two modes. In fully automated mode, the robotic arm conducts the surgery independently, while the surgeon monitors and oversees the procedure from a console. The second mode, called teleoperation or robotic assist, enables the surgeon to control the robot’s movements using a joystick, providing added flexibility during the operation.
Though the technology remains in the preclinical phase, Barzelay-Wollman emphasized its transformative potential. “This represents a pivotal leap in surgical robotics,” she said. “It combines superhuman precision with the elimination of hand tremors, making complex surgeries safer and more accessible.”
The next step for the team involves conducting in vivo studies on live animals to further refine the robotic system. Following successful trials, the platform will seek approval from the U.S. Food and Drug Administration (FDA) before advancing to human clinical trials.
If successful, this AI-driven robotic system could set a new standard in the field of ophthalmology, offering patients undergoing complex eye surgeries a safer, more precise alternative to traditional methods. This breakthrough could dramatically reshape the landscape of eye surgery, improving outcomes for those in need of advanced retinal and cataract procedures.
Related topic:
Visionary Eye Center: Comprehensive Eye Care in Jupiter
VISTA Eye Specialist Leads in Dry Eye Treatment with Groundbreaking Study
What Are The Best Lens For Cataract Surgery?
